Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01709617
Other study ID # 12-3-048
Secondary ID
Status Not yet recruiting
Phase N/A
First received October 11, 2012
Last updated October 16, 2012
Start date November 2012
Est. completion date January 2014

Study information

Verified date October 2012
Source Maastricht University Medical Center
Contact Naomi Cermak, Ph.D.
Phone 31433881393
Email naomi.cermak@maastrichtuniversity.nl
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

Carbohydrates are an integral component of sports nutrition. Providing carbohydrate (CHO) during exercise delays the onset of fatigue and improves exercise performance by maintaining high rates of CHO oxidation. Traditionally, glucose, or glucose polymers have been the preferential CHO source found in sports drinks. However, during the intestinal absorption of large amounts of glucose (>1.2 g/min), sodium-dependent glucose transporters (SGLT1) may become fully saturated, potentially limiting the rate of exogenous CHO oxidation. In an effort to evade this limitation, research has suggested using multiple transportable carbohydrates in the composition of sports drinks. Multiple transportable carbohydrates are combinations of simple sugars that use different intestinal transporters during the absorption process. Ingesting multiple transportable carbohydrates may enhance the capacity for total intestinal CHO absorption, leading to an increase in the rate of exogenous CHO oxidation. Our purpose will be to examine the disaccharide sucrose in it's ability to provide exogenous fuel during and following prolonged exercise.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 17
Est. completion date January 2014
Est. primary completion date September 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Healthy

- Male

- 18 - 40 years of age

- Endurance trained cyclist/triathlete

- VO2 max = 50 ml/kg/min

- BMI < 25 kg/m2

Exclusion Criteria:

- Use of medication

- Smoking

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)


Related Conditions & MeSH terms

  • Carbohydrate Oxidation and Glycogen Utilization During and Following Exercise

Intervention

Dietary Supplement:
Carbohydrate ingestion
Various types of carbohydrate ingested during and following exercise

Locations

Country Name City State
Netherlands Maastricht University Maastricht Limburg

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Exogenous carbohydrate oxidation rate (Part A) Carbohydrate oxidation as measured by breath samples 0 min during trials 1-3 No
Primary Endogenous carbohydrate oxidation (Part A) endogenous carbohydrate oxidation as measured through breath samples during trials 1-3 0 min during trials 1-3 No
Primary Glycogen utilization (Part B) Glycogen utilization measured through a muscle biopsy sample at post (~90 min), 3 and 6 h post exercise.
Part B; trials 4-6.
immediately post exercise (~90min), during trials 4-6 No
Primary Exogenous carbohydrate oxidation rate (Part A) Carbohydrate oxidation as measured by breath samples 30 min during trials 1-3 No
Primary Exogenous carbohydrate oxidation rate (Part A) Carbohydrate oxidation as measured by breath samples 60 min during trials 1-3 No
Primary Exogenous carbohydrate oxidation rate (Part A) Carbohydrate oxidation as measured by breath samples 90 min during trials 1-3 No
Primary Exogenous carbohydrate oxidation rate (Part A) Carbohydrate oxidation as measured by breath samples 120 min during trials 1-3 No
Primary Exogenous carbohydrate oxidation rate (Part A) Carbohydrate oxidation as measured by breath samples 150 min during trials 1-3 No
Primary Exogenous carbohydrate oxidation rate (Part A) Carbohydrate oxidation as measured by breath samples 180 min during trials 1-3 No
Primary Endogenous carbohydrate oxidation (Part A) endogenous carbohydrate oxidation as measured through breath samples during trials 1-3 30 min during trials 1-3 No
Primary Endogenous carbohydrate oxidation (Part A) endogenous carbohydrate oxidation as measured through breath samples during trials 1-3 60 min during trials 1-3 No
Primary Endogenous carbohydrate oxidation (Part A) endogenous carbohydrate oxidation as measured through breath samples during trials 1-3 90 min during trials 1-3 No
Primary Endogenous carbohydrate oxidation (Part A) endogenous carbohydrate oxidation as measured through breath samples during trials 1-3 120 min during trials 1-3 No
Primary Endogenous carbohydrate oxidation (Part A) endogenous carbohydrate oxidation as measured through breath samples during trials 1-3 150 min during trials 1-3 No
Primary Endogenous carbohydrate oxidation (Part A) endogenous carbohydrate oxidation as measured through breath samples during trials 1-3 180 min during trials 1-3 No
Primary Glycogen utilization (Part B) Glycogen utilization measured through a muscle biopsy sample at post (~90 min), 3 and 6 h post exercise.
Part B; trials 4-6.
3 h post exercise during trials 4-6 No
Primary Glycogen utilization (Part B) Glycogen utilization measured through a muscle biopsy sample at post (~90 min), 3 and 6 h post exercise.
Part B; trials 4-6.
6 h post exercise during trials 4-6 No
Secondary Indirect calorimetry (Part A) Measurements of VO2, VCO2 and RER through indirect calorimetry measured every 30 minutes during trials 1-3 every 30 min up to 180 min during trials 1-3 No
Secondary Plasma glucose Plasma glucose measurements every 30 min up to 180 min during trials 1-6 No
Secondary Plasma insulin plasma insulin measurements every 30 minutes up to 180 min during trials 1-6 No